tissue engineering

DURHAM, N.C., August 18, 2026 Humacyte, Inc. announced that its FDA-approved bioengineered blood vessel Symvess® has entered commercial use...

DURHAM, N.C., July 27, 2026 Humacyte, Inc. announced that the U.S. Food and Drug Administration (FDA) has accepted its...

EINDHOVEN, The Netherlands, July 7, 2026 Xeltis has announced the first commercial implantation of its aXess™ vascular access device,...

CAMBRIDGE, UK, May 19, 2026 Cyclana Bio announced that it has received Health Research Authority (HRA) and Research Ethics...

YOKOHAMA, Japan, May 7, 2026 CoreTissue BioEngineering announced the initiation of the randomized controlled cohort in its ongoing clinical...

ROSWELL, Ga., Feb. 12, 2026 — StimLabs announced that the U.S. Food and Drug Administration has granted 510(k) clearance...

Conshohocken, PA, November 28, 2025 Tiger BioSciences has spotlighted new scientific findings from a peer-reviewed study comparing 2-, 3-,...